Hepatic microvascular development in relation to the morphogenesis of hepatocellular plates in neonatal rats-Reference-Cited by-同舟云学术

Hepatic microvascular development in relation to the morphogenesis of hepatocellular plates in neonatal rats

Published:2003-10-02 Issue:1 Volume:275A Page:1019-1030
ISSN:0003-276X
Container-title:The Anatomical Record
language:en
Short-container-title:Anat. Rec.

Author:

McCuskey Robert S.,Ekataksin Wichai,LeBouton Albert V.,Nishida Jiro,McCuskey Margaret K.,McDonnell Deboragh,Williams Catherine,Bethea Nancy W.,Dvorak Bohuslav,Koldovsky Otakar

Publisher

Wiley

Subject

Agricultural and Biological Sciences (miscellaneous),Anatomy

Reference36 articles.

1. Morphological changes during hepatocellular maturity in neonatal rats

2. Hepatocyte Polyploidy and Metabolism/Life-history Traits: Hypotheses Testing

3. Development of ultrastructural heterogeneity among hepatocytes in the mouse

4. Enhancement of Neonatal Somatic and Hepatic Growth by Orally Administered Epidermal Growth Factor in Rats

5. Biologically active products of stimulated liver macrophages (Kupffer cells)

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normal Histological Developments of The Liver of Newborn Rats For Days (1, 3, 5, 7, and 10);Egyptian Journal of Veterinary Sciences;2025-06-01

2. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of drug concentration in blood;International Journal of Pharmaceutics;2024-06

3. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 3: Theoretical models of drug concentration in blood;International Journal of Pharmaceutics;2024-06

4. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood;International Journal of Pharmaceutics;2023-10

5. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors Part 3: Theoretical models of in vivo expansion, gastric residence time, and drug concentration in blood;International Journal of Pharmaceutics;2023-10